At CHASE, we specialise in designing, deploying, and managing partnerships that connect the life sciences industry with the NHS.
We help pharmaceutical, biotech, medtech, and healthcare organisations create projects that deliver measurable results for patients, alleviate NHS capacity challenges, and maximise the benefits of medicines and technology.
-7.avif)
“I would highly recommend CHASE as a go-to organisation to deliver service improvement initiatives that could benefit both pharma and the wider NHS.”
Director of Medicine Engagement
The NHS faces mounting challenges, including rising patient demand, an ageing workforce, and funding pressures. Collaborative working is no longer a luxury; it’s a necessity. Partnerships between the NHS and industry offer a powerful way to address these issues by improving healthcare delivery, reducing inequalities, and relieving pressure on overstretched systems.
Life sciences companies are expanding Market Access and Healthcare Partnership teams, while NHS systems are prioritising collaborative projects to drive patient care innovations.
With clear guidance frameworks from the ABPI, NHS Confederation, and The King's Fund, these partnerships deliver a “triple win”: improved patient outcomes, more efficient NHS operations, and better alignment with industry goals.
Partnering with CHASE delivers tangible outcomes that stand the test of time.
Here’s how we create value for all stakeholders:
Improved access to innovative medicines and technologies, optimised care pathways, and reduced health inequalities.
Alleviate capacity challenges, improve clinical workflows, andenhance patient experiences.
Ensure that medicines and technology are effectively deployed, reaching the patients who need them most.
Every project is designed in alignment with NHS requirements based on real-life clinicalexperience, guaranteeing lasting impact and scalability.
From patient recall systems to seamless integration between primary and secondary care, our programmes prioritise outcomes. Whether it’s optimising referral processes or reducing unnecessary hospital admissions, CHASE solutions are strategically designed with NHS clinician input.
Through Medacy, our sister company, we deliver pharmacist-led clinical programmes directly into NHS settings, enabling over 500,000 patient interactions annually. This hands-on experience ensures that actionable insights and real-world results back our programmes.
Patient Recall Systems
Enhance follow-up care and improve adherence to treatment plans.
Care Pathway Innovation
Streamline operations to reduce hospital admissions and improve patient satisfaction.
Clinical Data and Audit Outcomes
Demonstrate the value of industry contributions with robust reporting.
-6.avif)
As well as redesigning patient pathways, we can deploy a diverse range of roles to deliver NHS-industry projects, from nurses and prescribing clinical pharmacists to project managers, data analysts, and IT managers.
A leading pharma organisation commissioned us to supply an accurate feasibility study for a new clinical trial, looking specifically at sites & patient numbers.
Explore our latest thinking, event updates and industry insights about NHS-industry partnerships.
Discover how NHS-Industry partnerships will drive innovation in 2025 by tackling patient capacity, improving efficiency and boosting patient outcomes.
.jpg)
With the government halfway to its manifesto goal of 26,000 more primary care staff by March 2024, Cat Metcalfe of CHASE explores engaging clinical pharmacists.
"Many thanks for all CHASE’s efforts in leading this important work through an extremely challenging time for the NHS.
Your attention to detail, co-ordination of all the moving parts and ability to drive the project forward has been exemplary. Albeit we have been delayed by the pandemic, I know we would not have delivered the results achieved so far, without your efforts and for this CHASE deserve massive credit.
My experience has been such that I would highly recommend CHASE as a go-to organisation to deliver both R&D projects, or service improvement initiatives that could benefit both pharma and the wider NHS."
Director of Medicine Engagement
"The team at CHASE have demonstrated alignment to the project vision and high levels of accountability the whole way through from project planning to implementation and delivery.
Always professional, the team portray a strong sense of purpose and pace when engaging with our NHS partners, giving confidence regarding collaboration."
Medical Director
"CHASE are proving to be a fantastic partner to support and accelerate a truly innovative collaborative working project with the NHS.
I have full confidence in them consistently delivering by simultaneously meeting the needs of both industry and the NHS, which is particularly vital when working in an area of such complexity and when working at pace."
Senior Brand Manager
"It’s very motivating seeing patients being optimised on their medicines.
Being able to manage my own time effectively is also a real perk of the project."
Lead Pharmacist
Our success is built on trust, expertise, and an unparalleled understanding of the NHS landscape.
Trusted Clinical Practitioners
Our team includes NHS clinicians with first-hand experience, ensuring practical and actionable strategies.
Extensive NHS Network
Relationships with NHS ICSs, Trusts, PCNs, Health Innovation Networks, and primary and secondary care providers allow us to fast-track project implementation.
Sustainable Results
Every programme is designed with long-term sustainability in mind, ensuring lasting improvements for all stakeholders.
-6.avif)
The future of healthcare requires innovation, collaboration, and strategic partnerships. If you’re ready to lead the way, CHASE is here to make it happen. Contact us today to learn how we can help your organisation design and deliver impactful, sustainable NHS–Industry Projects.
Together, we’ll create partnerships that leave a lasting legacy.
.svg)
